Cormorant Asset Management

Cormorant Asset Management as of Dec. 31, 2015

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 82 positions in its portfolio as reported in the December 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alkermes (ALKS) 6.7 $56M 700k 79.38
Dyax 6.3 $53M 1.4M 37.62
Heron Therapeutics (HRTX) 5.4 $45M 1.7M 26.70
Eagle Pharmaceuticals (EGRX) 4.2 $36M 400k 88.67
Neurocrine Biosciences (NBIX) 4.1 $34M 604k 56.57
Omeros Corporation (OMER) 3.7 $31M 2.0M 15.73
Ardelyx (ARDX) 3.2 $27M 1.5M 18.12
Portola Pharmaceuticals 3.1 $26M 500k 51.45
Alder Biopharmaceuticals 3.0 $25M 758k 33.03
Quotient 2.9 $24M 1.5M 16.00
Alnylam Pharmaceuticals (ALNY) 2.8 $23M 245k 94.14
Sage Therapeutics (SAGE) 2.2 $18M 315k 58.30
Sorrento Therapeutics (SRNE) 2.2 $18M 2.1M 8.71
Nevro (NVRO) 2.1 $18M 265k 67.51
Aclaris Therapeutics (ACRS) 2.1 $18M 648k 26.94
China Biologic Products 1.9 $16M 112k 142.46
Mirati Therapeutics 1.9 $16M 495k 31.60
Macrogenics (MGNX) 1.9 $16M 500k 30.97
Tesaro 1.8 $15M 291k 52.32
Cellectis S A (CLLS) 1.7 $15M 469k 31.03
Dynavax Technologies (DVAX) 1.7 $14M 575k 24.16
Novavax 1.6 $13M 1.6M 8.39
Coherus Biosciences (CHRS) 1.6 $13M 569k 22.96
Nektar Therapeutics (NKTR) 1.5 $13M 765k 16.85
Dex (DXCM) 1.5 $13M 153k 81.90
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.5 $12M 450k 27.50
Ultragenyx Pharmaceutical (RARE) 1.5 $12M 110k 112.18
Rockwell Medical Technologies 1.4 $11M 1.1M 10.24
Vitae Pharmaceuticals 1.4 $11M 623k 18.10
BioCryst Pharmaceuticals (BCRX) 1.3 $11M 1.1M 10.32
Myokardia 1.3 $11M 753k 14.66
Acceleron Pharma 1.2 $9.8M 200k 48.76
Seres Therapeutics (MCRB) 1.1 $8.8M 250k 35.09
Lipocine 1.0 $8.6M 667k 12.93
Advaxis 1.0 $8.0M 800k 10.06
Pfenex 0.9 $7.7M 625k 12.38
Cytomx Therapeutics (CTMX) 0.9 $7.7M 371k 20.87
Agenus 0.8 $7.1M 1.6M 4.54
Recro Pharma 0.8 $7.0M 780k 9.00
Minerva Neurosciences 0.8 $7.0M 1.1M 6.07
Forward Pharma A/s 0.8 $6.4M 335k 19.00
Wave Life Sciences (WVE) 0.8 $6.3M 392k 15.95
Bellicum Pharma 0.7 $6.1M 300k 20.27
Dermira 0.7 $5.9M 170k 34.61
Achillion Pharmaceuticals 0.7 $5.4M 500k 10.79
Epizyme 0.5 $4.3M 266k 16.02
Kite Pharma 0.5 $4.2M 69k 61.61
Intec Pharma 0.5 $4.3M 800k 5.36
Celyad Sa 0.5 $4.1M 75k 54.59
Atara Biotherapeutics 0.5 $4.0M 150k 26.41
Lion Biotechnologies 0.5 $3.9M 500k 7.72
Immune Design 0.5 $3.8M 189k 20.08
Zynerba Pharmaceuticals 0.4 $3.6M 357k 10.07
Curis 0.4 $3.4M 1.2M 2.91
Epirus Biopharmaceuticals In 0.3 $2.8M 897k 3.09
Aptose Biosciences 0.3 $2.7M 1.1M 2.53
Blueprint Medicines (BPMC) 0.3 $2.6M 100k 26.34
Regenxbio Inc equity us cm (RGNX) 0.3 $2.6M 157k 16.60
Ovascience 0.3 $2.5M 252k 9.77
Genvec 0.3 $2.2M 1.2M 1.84
Tetralogic Pharmaceuticals c note 8.000% 6/1 0.2 $2.1M 5.0M 0.42
Aquinox Pharmaceuticals 0.2 $1.9M 150k 12.48
Agile Therapeutics 0.2 $1.8M 182k 9.76
Glycomimetics (GLYC) 0.2 $1.6M 284k 5.72
Amicus Therapeutics (FOLD) 0.2 $1.5M 150k 9.70
AVEO Pharmaceuticals 0.2 $1.4M 1.1M 1.26
Contrafect 0.1 $1.1M 234k 4.75
Ascendis Pharma A S (ASND) 0.1 $1.1M 62k 18.33
Veracyte (VCYT) 0.1 $994k 138k 7.20
Provectus Biopharmaceuticals I (PVCT) 0.1 $858k 2.2M 0.39
Htg Molecular Diagnostics 0.1 $876k 201k 4.36
Pronai Therapeutics 0.1 $799k 53k 15.03
Biotie Therapies Corp. ads 0.1 $718k 50k 14.36
Neos Therapeutics 0.1 $716k 50k 14.32
Nanostring Technologies (NSTGQ) 0.1 $588k 40k 14.70
Provectus Biopharmaceuticals *w exp 06/24/202 0.1 $550k 2.2M 0.25
Threshold Pharmaceuticals 0.1 $480k 1.0M 0.48
Cellectar Biosciences 0.1 $392k 530k 0.74
Applied Genetic Technol Corp C 0.0 $349k 17k 20.40
Cellectar Biosciences Inc *w exp 08/19/201 0.0 $297k 530k 0.56
Adaptimmune Therapeutics (ADAP) 0.0 $302k 25k 12.08
Regulus Therapeutics 0.0 $267k 31k 8.71